No Change of The Lipid Profile Under The Control of ApoE Gene Polymorphism in Schizophrenics Under Paliperidone Treatment
- 215 Downloads
The present study tried to explore the effects of Paliperidone on the lipid profiles of schizophrenia patients. One hundred twenty-nine subjects diagnosed with schizophrenia were enrolled into this study and completed the lipid profile evaluation. Their blood samples were obtained on the morning following a 12-hours fast. Cholesterol and triglyceride (TG) levels in plasma were determined, and lipoproteins were determined by enzymatic methods. All participants provided written informed consent, and underwent additional venous blood withdrawal for DNA extraction for genetic study of the ApoE gene polymorphism. Under T test, TC, TG and HDL levels all declined after Paliperidone treatment although with no statistically significant difference. The ratios of TC/HDL declined after Paliperidone treatment, but without statistically significant difference. After GEE-I analysis, we found that ApoE4 genotype (β = 34.471; p < 0.001) had a positive effect on the total cholesterol (TC) level; female had positive effect on the high-density lipoprotein (HDL) level (β = 15.361; p = 0.003); and age had a positive effect on the TG level (β = 1.317; p = 0.030). Smoking (β = 0.961; p = 0.016) had a positive effect on the ratio of TC/HDL change. Lipid profiles were not increased after Paliperidone treatment under the control of ApoE gene polymorphism.
KeywordsPaliperidone Schizophrenia ApoE gene polymorphism
All authors would like to acknowledge all researchers in Kaohsiung Armed Forced Hospital who assisted in this study.
- 4.Littrell K, Petty R, Hilligoss N, Kirshner C, Johnson C, Ortega T, et al. Insulin resistance and syndrome X among schizophrenia patients. San Francisco, USA: Meeting of the American Psychiatry Association; 2003.Google Scholar
- 13.Eggersten G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: Variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem. 1993; 39: 2125-9.Google Scholar
- 15.Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PW. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler Thromb. 1994; 14: 1105-3.PubMedCrossRefGoogle Scholar
- 23.Mahley RW, Pepin J, Palaoglu KE, Malloy MJ, Kane JP, Bersot TP. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype. J Lipid Res. 2000; 41: 1290-301.PubMedGoogle Scholar
- 24.Balakrishnan S, Colling C, B urkman T, Erickson J, Lyden E, Maheshwari H, et al. Apolipoprotein E gene polymorphism alters lipids before pancreas transplantation. Transplantation. 2002; 74: 974-7.Google Scholar
- 46.Yang MC, Chen KP, Lung FW. Generalized estimating equation model and long-term exposure effect of antipsychotics on SH-SY5Y cells against oxidative stressors. Eur J Pharmacol. 2014; Available online.Google Scholar
- 48.Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L. Oxidative stress involvement in schizophrenia pathophysiology: a review. L’Encephale. 2005; 32(2 Pt 1): 244-52.Google Scholar
- 53.Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59(suppl 20): 22-33.PubMedGoogle Scholar